{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:27:07Z","timestamp":1770956827463,"version":"3.50.1"},"reference-count":42,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UO1AG22376"],"award-info":[{"award-number":["UO1AG22376"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007154","name":"Wake Forest University","doi-asserted-by":"publisher","award":["1 P30 AG21332"],"award-info":[{"award-number":["1 P30 AG21332"]}],"id":[{"id":"10.13039\/100007154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008090","name":"Tufts University","doi-asserted-by":"publisher","award":["1P30AG031679"],"award-info":[{"award-number":["1P30AG031679"]}],"id":[{"id":"10.13039\/100008090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","award":["P30AG024827"],"award-info":[{"award-number":["P30AG024827"]}],"id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005326","name":"Yale University","doi-asserted-by":"publisher","award":["P30AG021342"],"award-info":[{"award-number":["P30AG021342"]}],"id":[{"id":"10.13039\/100005326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Proton pump inhibitors (<jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>s) and histamine<jats:sub>2<\/jats:sub> receptor antagonists (H<jats:sub>2<\/jats:sub><jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>s) are associated with pharmacologic effects that may be detrimental to mobility and response to physical activity. Mobility disability and injurious fall outcomes in <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content> and H<jats:sub>2<\/jats:sub><jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> users were compared with nonusers in this secondary analysis of data from the Lifestyle Interventions for Elders (<jats:styled-content style=\"fixed-case\">LIFE<\/jats:styled-content>) study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Participants ages 70\u201389\u00a0years were randomized to a physical activity (<jats:styled-content style=\"fixed-case\">PA<\/jats:styled-content>) or successful aging intervention and evaluated by medication use. Confounders included baseline demographic characteristics, physical function, cognitive function, sleep quality, and acid reflux symptoms that were adjusted via propensity score weighting. Outcomes were incident and persistent major mobility disability (<jats:styled-content style=\"fixed-case\">MMD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">pMMD<\/jats:styled-content>) and injurious falls. Weighted proportional hazard models evaluated independent and interaction effects of <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>s and H<jats:sub>2<\/jats:sub><jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>s.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No interaction was found between <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>s and H<jats:sub>2<\/jats:sub><jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>s and the <jats:styled-content style=\"fixed-case\">PA<\/jats:styled-content> intervention. Drug use associations were significant for H<jats:sub>2<\/jats:sub><jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>s (hazard ratio [HR] 1.74 [95% confidence interval [CI] 1.12\u20132.68]) and <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>s (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content> 1.32 [95% CI 1.02\u20131.70]) compared with nonusers for <jats:styled-content style=\"fixed-case\">pMMD<\/jats:styled-content>. <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>s were associated with increased injurious falls compared with nonusers (HR 1.44 [95% CI 1.06\u20131.96]). Pooling of data from the H<jats:sub>2<\/jats:sub><jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content> exposure groups showed a 26% increase in <jats:styled-content style=\"fixed-case\">MMD<\/jats:styled-content> (HR 1.26 [95% CI 1.07\u20131.48]), a 44% increase in <jats:styled-content style=\"fixed-case\">pMMD<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content> 1.44 [95% CI 1.16\u20131.77]), and a 48% increase in injurious falls (HR 1.48 [95% CI 1.15\u20131.91]) compared with nonusers. All direct comparisons between <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>s and H<jats:sub>2<\/jats:sub><jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>s were nonsignificant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Compared with nonusers, participants using either <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>s or H<jats:sub>2<\/jats:sub><jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>s had an increased risk of <jats:styled-content style=\"fixed-case\">MMD<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> pMMD<\/jats:styled-content>, and injurious falls. It is not known if these effects are related to the individual pharmacology of each medication, reduced acid secretion, or the underlying disease state. Further study is required to determine causality.<\/jats:p><\/jats:sec>","DOI":"10.1002\/phar.2299","type":"journal-article","created":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T07:23:31Z","timestamp":1561274611000},"page":"816-826","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of Gastric Acid Suppressants on Response to a Physical Activity Intervention and Major Mobility Disability in Older Adults: Results from the Lifestyle Interventions for Elders (<scp>LIFE<\/scp>) Study"],"prefix":"10.1002","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0723-6839","authenticated-orcid":false,"given":"Patrick J.","family":"Squires","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Outcomes &amp; Policy University of Florida College of Pharmacy Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pahor","sequence":"additional","affiliation":[{"name":"Institute on Aging Department of Aging and Geriatric Research University of Florida College of Medicine Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd M.","family":"Manini","sequence":"additional","affiliation":[{"name":"Institute on Aging Department of Aging and Geriatric Research University of Florida College of Medicine Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes &amp; Policy University of Florida College of Pharmacy Gainesville Florida"},{"name":"Center for Drug Evaluation &amp; Safety University of Florida Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1123\/japa.7.1.7"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.17.2018"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glv222"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glz120"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glt088"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2010.11.002"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glp005"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gln038"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2009.09.014"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.01797.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.5009\/gnl15502"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.04.014"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0910389"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc082292"},{"issue":"10","key":"e_1_2_6_16_1","first-page":"725","article-title":"Adverse risks associated with proton pump inhibitors","volume":"5","author":"Heidelbaugh JJ","year":"2009","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124653"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.7193"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glr123"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glt064"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/49.2.M85"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.5616"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i245"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_293.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1903"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280213519716"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3697"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.952"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-200201000-00004"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2007.01270.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00155"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0576-z"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-016-0679-0"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2279"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2008.07.002"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.1.209"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-012-8311-8"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2013.11.006"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003602"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2773"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12697"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu5114462"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-010-0141-0"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fphar.2299","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2299","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/phar.2299","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:14:29Z","timestamp":1761052469000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.2299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1002\/phar.2299"],"URL":"https:\/\/doi.org\/10.1002\/phar.2299","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"2019-07-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}